Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine for treating rheumatism and lumbar disc protrusion and production method thereof

A lumbar intervertebral disc herniation and drug technology, applied in the lumbar intervertebral disc herniation drug, in the field of treatment of rheumatism, can solve the problems of easy recurrence, high cost, no good treatment method for the sequelae of cerebral thrombosis and hemiplegia, etc.

Active Publication Date: 2014-10-08
王应江
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Lumbar disc herniation is one of the more common diseases, mainly because various parts of the lumbar intervertebral disc (nucleus pulposus, annulus fibrosus, and cartilage plate), especially the nucleus pulposus, have degenerative changes to varying degrees, and under the action of external forces , the annulus fibrosus of the intervertebral disc ruptures, and the nucleus pulposus protrudes (or protrudes) from the rupture to the rear or in the spinal canal, causing irritation or compression of the adjacent spinal nerve roots, resulting in low back pain, numbness and pain in one or both lower limbs and a series of clinical symptoms; the existing treatment is divided into surgical treatment and non-surgical treatment. Non-surgical treatment is mainly aimed at patients with mild symptoms, and the cure is slow. , Percutaneous transforaminal endoscopic intervertebral disc removal and other minimally invasive surgical techniques reduce surgical damage and achieve good results, but the cost is high and recurrence is easy
[0008] However, there is no good treatment for the sequelae of cerebral thrombosis and hemiplegia. Rehabilitation treatment is often used now, and the effect is relatively slow.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1: Take 30g portions of black ants, 25g soil yuan, 50g rock horse mulberry, Drynaria fortunei 50g, vetch 8g, tenuigrass 25g, Lulutong 25g, Tougucao 25g and Dilong 25g, and put in The wine jar is filled with 20kg of corn wine, and the jar is sealed, and it can be taken after half a month of storage; the amount of each serving is 3-5 yuan, twice a day.

Embodiment 2

[0029] Example 2: Take 60g of black ant, 35g of soil element, 70g of rock horse mulberry, drynaria 70g, asarum 12g, 35g of viridis, 35g of Passepartout, 35g of Tougucao and 35g of Dilong In the wine jar of 20kg corn wine, the jar is sealed, and it can be taken after storage for half a month; the amount of each serving is 3-5 yuan, twice a day.

Embodiment 3

[0030] Example 3: Take 45g of black ant, 30g of soil element, 60g of rock horse mulberry, drynaria 60g, asarum 10g, 30g of sclerotium, 30g of Passepartout, 30g of Tougucao and 30g of Dilong In the wine jar of 20kg corn wine, the jar is sealed, and it can be taken after storage for half a month; the amount of each serving is 3-5 yuan, twice a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating rheumatism and lumbar disc protrusion and a production method thereof. The medicine is prepared from the following raw materials in parts by weight: 30-60 parts of black ant, 25-35 parts of ground beetle, 50-70 parts of chimonanthus nitens, 50-70 parts of rhizoma drynariae, 8-12 parts of asarum insigne Diels, 25-35 parts of herba lycopodii, 25-35 parts of fructus liquidambaris, 25-35 parts of trberculate speranskia herb and 25-35 parts of pheretima. The medicines employs the treatment fundament of unblocking meridian and activating collaterals, dispelling wind and eliminating dampness, activating blood and resolving stasis, dispersing swelling and relieving pain. Corn wine is employed to assist to the medicine effectiveness to directly reach nidus, and the bulk drugs together give play to magical effect. Clinical verification for more than ten years prove that the medicine has no any toxic and side effects for treating more than five thousands of patients.

Description

Technical field [0001] The invention relates to a medicine and a method for treating rheumatism and lumbar disc herniation, and belongs to the technical field of Chinese herbal medicine. Background technique [0002] Rheumatic diseases are autoimmune diseases that invade multiple tissues, systems and internal organs. Different degrees of immune inflammation can cause various tissues and organs damage, seriously affect their normal functions, and even cause fatal damage. The existing drugs for treating rheumatic diseases can be divided into the following categories: [0003] 1. Non-steroidal anti-inflammatory drugs (NSAIDs): The effects of these drugs are mainly antipyretic, anti-inflammatory and analgesic, and achieve the purpose of reducing inflammation. The first was aspirin (acetylsalicylic acid) and is still an effective drug for the treatment of acute rheumatic fever and rheumatoid arthritis. Later, a variety of salicylic acid drugs were produced, commonly used are ibuprofe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/47A61K36/268A61K36/8945A61P29/00A61P19/08A61K35/56A61K35/64
Inventor 王应江
Owner 王应江
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products